Coldstream Capital Management Inc. Boosts Stock Holdings in Humana Inc. (NYSE:HUM)

Coldstream Capital Management Inc. lifted its stake in Humana Inc. (NYSE:HUM) by 2.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,735 shares of the insurance provider’s stock after buying an additional 40 shares during the period. Coldstream Capital Management Inc.’s holdings in Humana were worth $794,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Dorsey & Whitney Trust CO LLC boosted its stake in shares of Humana by 2.6% during the third quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock valued at $397,000 after purchasing an additional 21 shares during the period. First Financial Corp IN boosted its position in Humana by 7.2% during the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after buying an additional 23 shares during the period. Walker Financial Services Inc. grew its holdings in Humana by 3.9% in the 4th quarter. Walker Financial Services Inc. now owns 795 shares of the insurance provider’s stock worth $364,000 after acquiring an additional 30 shares during the last quarter. Signaturefd LLC increased its position in shares of Humana by 1.2% in the fourth quarter. Signaturefd LLC now owns 2,634 shares of the insurance provider’s stock valued at $1,206,000 after acquiring an additional 30 shares during the period. Finally, Brighton Jones LLC raised its stake in shares of Humana by 6.8% during the fourth quarter. Brighton Jones LLC now owns 470 shares of the insurance provider’s stock valued at $215,000 after acquiring an additional 30 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the topic of several recent analyst reports. Bank of America raised their target price on Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research note on Monday. Wells Fargo & Company decreased their target price on Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Raymond James started coverage on shares of Humana in a report on Friday, March 22nd. They issued a “market perform” rating on the stock. Cantor Fitzgerald decreased their price objective on shares of Humana from $391.00 to $360.00 and set a “neutral” rating for the company in a report on Thursday, April 25th. Finally, Stephens dropped their target price on shares of Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a research report on Friday, January 26th. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $426.39.

Humana Price Performance

HUM opened at $355.59 on Wednesday. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54. The stock has a 50-day moving average price of $322.40 and a 200-day moving average price of $374.54. The firm has a market cap of $42.85 billion, a PE ratio of 22.14, a P/E/G ratio of 2.07 and a beta of 0.50. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business’s revenue was up 10.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $9.38 earnings per share. Sell-side analysts predict that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s payout ratio is 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.